Zobrazeno 1 - 10
of 398
pro vyhledávání: '"Juan J. Gomez‐Reino"'
Autor:
Christopher T. Ritchlin, Jon T. Giles, Alexis Ogdie, Juan J. Gomez‐Reino, Philip Helliwell, Pamela Young, Cunshan Wang, Joseph Wu, Ana Belén Romero, John Woolcott, Lori Stockert
Publikováno v:
ACR Open Rheumatology, Vol 2, Iss 10, Pp 543-554 (2020)
Objective Metabolic syndrome (MetS) is a cluster of concurrent risk factors for cardiovascular disease and type 2 diabetes. This post hoc analysis explored key efficacy and safety endpoints in patients with psoriatic arthritis (PsA) and MetS treated
Externí odkaz:
https://doaj.org/article/fc2e3eed87934869ad35765b8844ae75
Autor:
Philip J. Mease, Dafna D. Gladman, Juan J. Gomez‐Reino, Stephen Hall, Arthur Kavanaugh, Eric Lespessailles, Georg Schett, Maria Paris, Nikolay Delev, Lichen Teng, Jürgen Wollenhaupt
Publikováno v:
ACR Open Rheumatology, Vol 2, Iss 8, Pp 459-470 (2020)
Objective Psoriatic arthritis (PsA) requires long‐term treatment, yet safety concerns and monitoring requirements make maintenance a challenge. This analysis of pooled Psoriatic Arthritis Long‐term Assessment of Clinical Efficacy (PALACE) 1, 2, a
Externí odkaz:
https://doaj.org/article/fa93086f13fa47d6bce83b4a9731f08f
Autor:
José Vicente Moreno Muelas, Miguel Ángel Abad Hernández, Federico Díaz-González, Juan J. Gomez-Reino, Alejandro Balsa Criado, Rubén Queiro Silva, José Luis Andreu
Publikováno v:
Reumatología Clínica. 17:160-169
espanolEn el ano 2015 la Sociedad Espanola de Reumatologia (SER) publico su posicionamiento sobre farmacos biosimilares. En esta actualizacion, la SER, sigue manifestando su compromiso inequivoco con la sostenibilidad del sistema sanitario de nuestro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9b1939b57c984e3a6f28450660f1cd5
https://doi.org/10.1016/j.reuma.2019.03.007
https://doi.org/10.1016/j.reuma.2019.03.007
Autor:
Miguel Ángel Abad Hernández, Alejandro Balsa Criado, Rubén Queiro Silva, Juan J. Gomez-Reino, Federico Díaz-González, José Vicente Moreno Muelas, José Luis Andreu
Publikováno v:
Reumatología Clínica (English Edition). 17:160-169
In 2015 the Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia [SER]) published its position paper on biosimilar drugs. In this update, the SER, continues to manifest its unequivocal commitment to the sustainability of the health syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b955255ad35d46d161630983d9464fa
https://doi.org/10.1016/j.reumae.2019.03.003
https://doi.org/10.1016/j.reumae.2019.03.003
Publikováno v:
Patient preference and adherence
Manuel Pombo-Suarez,1 Jose Ramon Maneiro Fernandez,2 Juan Jesus Gomez-Reino3 1Rheumatology Service, Complejo Hospitalario Universitario, Santiago de Compostela, Spain; 2Rheumatology Service, Complejo Hospitalario Universitario, Pontevedra, Spain; 3Fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff92e4c46ec5191f62e2d00af0356861
https://doi.org/10.2147/ppa.s291983
https://doi.org/10.2147/ppa.s291983
Autor:
Juan J. Gomez-Reino, Stephen Hall, Philip J. Mease, Georg Schett, N. Delev, Dafna D. Gladman, L. Teng, Eric Lespessailles, Jürgen Wollenhaupt, Maria Paris, Arthur Kavanaugh
Publikováno v:
ACR Open Rheumatology, Vol 2, Iss 8, Pp 459-470 (2020)
ACR Open Rheumatology
ACR Open Rheumatology, 2020, ⟨10.1002/acr2.11156⟩
ACR Open Rheumatology
ACR Open Rheumatology, 2020, ⟨10.1002/acr2.11156⟩
OBJECTIVE Psoriatic arthritis (PsA) requires long-term treatment, yet safety concerns and monitoring requirements make maintenance a challenge. This analysis of pooled Psoriatic Arthritis Long-term Assessment of Clinical Efficacy (PALACE) 1, 2, and 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af41e432a10f189798b6e0b38a4874d5
https://doaj.org/article/fa93086f13fa47d6bce83b4a9731f08f
https://doaj.org/article/fa93086f13fa47d6bce83b4a9731f08f
Autor:
Dmitrij Kollins, Liyi Cen, Josef S Smolen, Tamas Shisha, Juan J. Gomez-Reino, Hans-Peter Tony, Andra Balanescu, Alan Kivitz, Stanley Cohen, Johann Poetzl, Morton Scheinberg
Publikováno v:
Rheumatology. 60:256-262
Objectives This report provides data for the extent of B cell depletion and recovery, efficacy, safety and immunogenicity of Sandoz rituximab (SDZ-RTX; GP2013; Rixathon®) compared with reference rituximab (Ref-RTX) up to week 52 of the ASSIST-RA stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9309b702eb5920a8ae8bfcafd756aac2
https://doi.org/10.1093/rheumatology/keaa234
https://doi.org/10.1093/rheumatology/keaa234
Autor:
Eduardo Cuende, M. Victoria Hernández Miguel, Raquel Martín Domenech, Rosa Roselló, Jesús T. Sánchez-Costa, Carlos Sánchez-Piedra, Javier del Pino-Montes, Jesús Carlos Fernández-Lopez, Carlos Rodríguez-Lozano, Ana Milena Millan-Arciniegas, Javier Manero, Eva Perez-Pampin, en representación del Grupo de trabajo Biobadaser Fase, Juan J. Gomez-Reino, Sagrario Bustabad, Federico Díaz-González, Cristina Campos
Publikováno v:
Reumatología Clínica. 15:229-236
Objective Describe the objectives, methods and results of the first year of the new version of the Spanish registry of adverse events involving biological therapies and synthetic drugs with an identifiable target in rheumatic diseases (BIOBADASER III
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2af93ac61953c02a7f7ee7d34b76908
https://doi.org/10.1016/j.reuma.2017.08.001
https://doi.org/10.1016/j.reuma.2017.08.001
Autor:
Emma Beltran-Catalan, Eva Salgado, Marta Valero, José Vicente Moreno-Muelas, Inma Calvo-Penades, Patricia Carreira, Mariluz Garcia-Vivar, Montserrat Romera-Baurés, Agusti Sellas-Fernández, Juan J. Gomez-Reino, Esperanza Naredo, Alina Boteanu
Publikováno v:
Seminars in arthritis and rheumatism. 52
Background In immune-mediated inflammatory rheumatic diseases (IMIRD), there are differences between cis-men and cis-women in epidemiology, clinical feature, therapeutic approach, treatment response, and prognosis. In transgender individuals, informa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac3462e8b829dc76faf4829c9774de48
https://pubmed.ncbi.nlm.nih.gov/36108530
https://pubmed.ncbi.nlm.nih.gov/36108530
Autor:
Cesar Diaz-Torne, Mercedes Freire, Rocio Caño, J. M. Blanco-Madrigal, Juan J. Gomez-Reino, Inmaculada Ros-Vilamajo, Lourdes Mateo, Cristina Bohórquez, Carlos Sánchez-Piedra, Paloma Vela, Fernando Sánchez-Alonso, M.C. Castro-Villegas, Federico Díaz-González, Silvia Gómez, Carolina Pérez-García
Publikováno v:
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-9 (2020)
ARTHRITIS RESEARCH & THERAPY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-9 (2020)
ARTHRITIS RESEARCH & THERAPY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Objectives: To assess whether age, at the beginning of biologic treatment, is associated with the time a first adverse event (AE) appears in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), or psoriatic arthritis (PsA). Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87379295985d242fdeda9e11be761d76
https://doi.org/10.1186/s13075-020-02231-x
https://doi.org/10.1186/s13075-020-02231-x